Key terms
About XXII
22nd Century Group, Inc. is a biotechnology company, which engages in the business of tobacco harm reduction, reduced nicotine tobacco, and improvement of health and wellness through plant science. It operates through the Tobacco and Hemp/Cannabis segments. The Tobacco segment manufactures branded filtered cigars and cigarettes. The Hemp/Cannabis segment focuses on the bulk ingredient distillate or isolate. The company was founded on September 12, 2005 and is headquartered in Buffalo, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest XXII news
Today
8:05am ET
Options Volatility and Implied Earnings Moves Today, March 28, 2024
Mar 25
8:00am ET
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
Feb 15
4:45pm ET
22nd Century Expands Stock Capacity for Growth Potential
Feb 13
4:44pm ET
22nd Century Board Adopts New Compensation Strategy
Jan 26
4:15am ET
22nd Century Executives End Contracts, Continue At-Will
Jan 26
4:14am ET
22nd Century Announces Definitive Agreement Termination
Jan 25
4:39am ET
22nd Century Announces Special Meeting Outcomes and Adjournment
Jan 25
4:38am ET
22nd Century Stockholders Approve Key Proposals
Jan 17
12:45pm ET
22nd Century to hold an update conference call
Jan 17
10:44am ET
22nd Century to hold an update conference call
No recent news articles are available for XXII
XXII Financials
Key terms
Ad Feedback
XXII Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
XXII Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range